KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Non-cash Items (2016 - 2025)

Historic Non-cash Items for Xenon Pharmaceuticals (XENE) over the last 13 years, with Q3 2025 value amounting to $6.4 million.

  • Xenon Pharmaceuticals' Non-cash Items rose 709.92% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.4 million, marking a year-over-year increase of 709.92%. This contributed to the annual value of $111.2 million for FY2024, which is 4443.29% down from last year.
  • Per Xenon Pharmaceuticals' latest filing, its Non-cash Items stood at $6.4 million for Q3 2025, which was up 709.92% from $6.3 million recorded in Q2 2025.
  • Xenon Pharmaceuticals' Non-cash Items' 5-year high stood at $200.1 million during Q4 2023, with a 5-year trough of $2.8 million in Q1 2021.
  • In the last 5 years, Xenon Pharmaceuticals' Non-cash Items had a median value of $5.4 million in 2024 and averaged $33.3 million.
  • In the last 5 years, Xenon Pharmaceuticals' Non-cash Items surged by 24599.86% in 2021 and then tumbled by 4443.29% in 2024.
  • Quarter analysis of 5 years shows Xenon Pharmaceuticals' Non-cash Items stood at $105.4 million in 2021, then surged by 39.67% to $147.2 million in 2022, then surged by 35.94% to $200.1 million in 2023, then crashed by 44.43% to $111.2 million in 2024, then tumbled by 94.25% to $6.4 million in 2025.
  • Its Non-cash Items stands at $6.4 million for Q3 2025, versus $6.3 million for Q2 2025 and $6.5 million for Q1 2025.